Abstract: Although radiotherapy has been widely applied to treating cervical cancer in the clinic, its therapeutic efficacy is often restricted to the radioresistance of cancer cells. Retinoblastoma protein-interacting zinc finger gene 1 (RIZ1) has been suggested as a tumour suppressor gene, whereas its role in cervical cancer with or without radiotherapy has been unclear. In this study, two cervical cancer cell lines, HeLa and SiHa cells, stably transfected with RIZ1 overexpression plasmid were subjected to ionizing radiation, and their survival fractions were calculated by assessing their clonogenic abilities. Our results showed that the forced overexpression of RIZ1 significantly reduced the clonogenic survival rates of both HeLa and SiHa cells exposed to ionizing radiation. By analysing the cell apoptotic status, we found that the RIZ1-overexpressed cervical cancer cells under ionizing radiation were more vulnerable to damage, and more c-H2AX foci were found in these cells. Furthermore, the volumes of tumour xenografts formed by the RIZ1-overexpressed cells in nude mice under ionizing radiation were smaller than those generated by the control cells. There were more morphological changes, apoptosis cells and lower expression of PCNA in RIZ1-overexpressed tumour tissues of mice after exposure to ionizing radiation. Taken together, our study demonstrates that the overexpression of RIZ1 combined with radiotherapy facilitates apoptosis and DNA damage of cervical cancer cells.
Cervical cancer, one of common gynaecological cancers, ranks the fourth place of female cancers and is the fourth death cause of malignancy worldwide [1, 2] . Almost 80% of cases are found in developing countries, and most patients have an advanced stage of cervical cancer [3] . Radiotherapy is one of the main treatment methods for cervical cancer [4] , which has direct anticancer effects via the induction of DNA damage. However, radioresistance may occur in patients with cervical cancer during the course of radiotherapy, leading to a reduced therapeutic efficiency. Therefore, there is an urgent need to identify novel optimized measure in the radiotherapy of these cancer cells.
Retinoblastoma protein-interacting zinc finger gene (RIZ), located on chromosome 1q36, is a member of the nuclear protein-methyltransferase superfamily [5] . RIZ1 and RIZ2 are two types of protein products of the RIZ gene [6, 7] . RIZ1 contains a conserved positive regulatory PR domain, while RIZ2 does not. RIZ1, but not RIZ2, is confirmed to be a tumour suppressor, and its expression is down-regulated or lost in various human tumours [8] [9] [10] [11] . Furthermore, it is reported that methylation in the RIZ1 gene promoter region is the main reason for its transcriptional silencing [7, 12, 13] . Growing evidence has demonstrated that the low expression of RIZ1 is associated with the advanced progression of various tumours, such as endometrial cancer [14] , hepatocellular carcinoma [15] , myelogenous leukaemia [16] and ovarian carcinoma [17] . RIZ1 overexpression can promote apoptosis of human oesophageal squamous cell carcinoma cells in vitro [18] , whereas its silencing is correlated with cervical cancer development [19] . Of note, our previous study indicated that the overexpression of RIZ1 augmented the anticancer effects of paclitaxel, a chemotherapeutic drug, in cervical cancer cells [20] . As RIZ1 plays a role in the chemotherapy of cervical cancer cells, we decided to further evaluate its role in cervical cancer when combined with radiotherapy.
In this study, we investigated the anticancer effect of the combination of RIZ1 overexpression and radiotherapy on HeLa and SiHa cervical cancer cells in vitro and in vivo through evaluating proliferation, apoptosis and DNA damage.
Materials and Methods
Cell lines and culture. The HeLa and SiHa cell lines were purchased from the Shanghai Cell Institute Country Cell Bank and cultured in Dulbecco's modified Eagle Medium (DMEM, 12100-46; Gibco, Waltham, MA, USA) supplemented with 10% foetal bovine serum (SH30084.03; Hyclone, Logan, UT, USA) at 37°C in an atmosphere of 5% CO 2 . Cells were exposed to various single doses of X-ray irradiation using a linear accelerator (Varian Medical Systems, Palo Alto, CA, USA).
Generation of stable RIZ1-overexpressed cell lines. To assess the role of RIZ1 in radiosensitivity of cervical cancer cells, we established RIZ1 stably transfected cell lines. The HeLa and SiHa cells were transfected with RIZ1 overexpression plasmid (pCMV3-untagged vector, HG11216-UT; Sino Biological, Beijing, China) or control empty vector using Lipofectamine 2000 Reagent (1024993; Invitrogen, Carlsbad, CA, USA) according to supplier's instructions. Twenty-four hours later, 70 lg/ml hygromycin was added to cell culture media for 2 weeks to select the cell clones with resistance to hygromycin.
Western blot analysis. The protein levels were detected by Western blot. Briefly, the transfected cells at a confluence of 90% were plated into the 60-mm dishes and radiated with a dose of 0 or 6 Gy. Then cells were lysed via RIPA buffer (P0013B; Beyotime, Haimen, China), and protein concentration was detected by an Enhanced BCA Protein Assay Kit (P0009, Beyotime). The protein sample was separated on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto polyvinylidene difluoride membranes (IPVH00010; Millipore, Bedford, MA, USA) and blocked with 5% skim milk. Then, the membranes were incubated with primary antibodies for RIZ1 (1:300, D161843, Sangon Biotech, Shanghai, China) or b-actin (1:1000, KGAA006-1; Keygen, Nanjing, China), cleaved caspase-3 (1:1000, #9661; Cell Signaling Technology, Boston, MA, USA), cleaved PARP (1:1000, #9548; Cell Signaling Technology), P53 (1:1000, #9282; Cell Signaling Technology), 53BP1 (1:500, bs-2740R; Bioss, Woburn, MA, USA) at 4°C overnight, followed by an incubation with HRP-conjugated goat anti-rabbit secondary antibody (A0208, 1:5000; Beyotime) at 37°C for 45 min. The bands were visualized using ECL reagent (P0018, Beyotime).
Quantitative real-time polymerase chain reaction (qPCR). The mRNA expression of RIZ1 in HeLa and SiHa cells was determined by qPCR. Briefly, total RNAs were isolated by TRIzol according to the manufacturer's instructions. Then, the RNAs were reversely transcribed by the Super M-MLV reverse transcriptase (PR6502; BioTeke, Beijing, China). qPCR was performed using 2 9 Power Taq PCR MasterMix (PR1702; BioTeke). The primer sequences were as follows: Flow cytometry for cell apoptosis analysis. Apoptosis is confirmed to be one of the main forms of ionizing radiation-induced cell death [21] , so we next evaluated the effect of RIZ1 overexpression on cell apoptosis after exposure to ionizing radiation. The transfected cells at a confluence of 90% were plated into the 60-mm dishes and subjected to radiotherapy. Cell apoptosis was detected by annexin V/propidium iodide stains via flow cytometry. Briefly, cancer cells exposed to various doses of radiation were collected and incubated with Annexin V-FITC and PI staining mixture (WLA001c; Wanleibio, Shenyang, China) for 15 min. at room temperature in the dark. The samples were then subjected to flow cytometry (BD, Franklin Lakes, NJ, USA) to identify the apoptotic cells.
Immunofluorescence staining. c-H2AX plays an important role in DNA damage and repair, and its foci within cells can be used to evaluate the radiation-induced DNA double-strand break [22] . Briefly, the HeLa and SiHa cells at a confluence of 90% in 60-mm dishes received various doses of radiation, were then seeded in coverslips and were fixed in 4% paraformaldehyde for 15 min. After washing, the cells were permeabilized in 0.1% Triton X-100 for 30 min. and then blocked with normal goat serum for 15 min. at room temperature. Thereafter, cells were incubated with c-H2AX primary antibody ( The mRNA expression of RIZ1 was detected by qPCR. At least three independent experiments were performed to obtain the results. All data were expressed as means AE S.D. (n = 3). Unpaired Student's t-test was performed to compare differences between two groups. **p < 0.01, ***p < 0.001, versus the vector group.
Beyotime) for 1 hr at room temperature. Cell nuclei were stained with DAPI. Cell images were taken under a fluorescence microscope (Olympus, Tokyo Japan) at a magnification of 2009.
In vivo tumour growth assay. Athymic nude mice purchased from Beijing Vital River Laboratory Animal Co., Ltd. (Beijing, China) were used to evaluate the tumour growth in vivo. The mice were raised in pathogen-free standard conditions with access to food and water ad libitum. Stably transfected HeLa and SiHa cells (1 9 10 7 /ml, 0.2 ml) were subcutaneously injected into the axilla. The mouse state was monitored every day, and the tumour diameters were measured every 3 days. The tumour volumes were calculated as follows: 4p/ 3 9 (width/2) 2 9 (length/2). When the tumour volume of mouse in the vector group reached about 300 mm 3 , the mice were subjected to a single dose of 10 Gy or 15 Gy radiotherapy. The experimental groups were as follows: HeLa-vector-10 Gy, HeLa-vector-15 Gy, HeLa-RIZ1-10 Gy, HeLa-RIZ1-15 Gy, SiHa-vector-10 Gy, SiHavector-15 Gy, SiHa-RIZ1-10 Gy, SiHa-RIZ1-15 Gy. On day 30 after cell injection, the mice were killed by cervical dislocation, and tumour tissues were removed, weighed and stored in liquid nitrogen for subsequent experiments. The experiments were approved by the Institutional Animal Care and Use Committee of Harbin Medical University.
Haematoxylin-eosin (H&E) staining. The tumour tissues in each group were fixed in 4% paraformaldehyde, embedded into paraffin and then sectioned into 5-lm slices. Then, the slices were subjected to routine haematoxylin and eosin staining and photographed under a microscope (Olympus) at a magnification of 2009.
Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining. The apoptotic cells within the tumour masses were probed with a TUNEL apoptosis detection kit (WLA029; Wanleibio, Shenyang, China) according to the manufacturer's instructions. The images were photographed under a microscope at a magnification of 4009.
Immunohistochemistry staining. The expressions of RIZ1 and PCNA in tumour tissues were assessed by immunohistochemistry staining. The paraffin-embedded 5-lm tumour sections were immersed in xylene and dehydrated in graded concentrations of alcohol successively. Then, the sections were incubated with a retrieval solution in the microwave for 10 min. at low power. After blocking with normal goat serum for 15 min. at room temperature, the sections were probed with RIZ1 (1:30, D161843; Sangon, Shanghai, China) or PCNA (1:200, 10205-2-AP; Proteintech, Wuhan, China) primary antibody at 4°C overnight and then with biotinylated goat anti-rabbit secondary antibody (1:200, A0277; Beyotime) at 37°C for 30 min. Finally, the sections were treated with DAB staining buffer and counterstained with haematoxylin. The pictures were taken by a light microscope at a magnification of 4009.
Statistical analysis. GraphPad Prism 5 (GraphPad Prism 5 Inc., La Jolla, CA, USA) software was used for all statistical analyses. All experimental data were presented as mean AE standard deviation (S.D.). Unpaired Student's t-test was performed to compare differences between two groups. The statistical significance was set as p value <0.05.
Results
Expression of RIZ1 in cervical cancer cells. The efficiency of RIZ1 overexpression plasmid transfected into HeLa and SiHa cells was detected by Western blot and qPCR assays. As shown in fig. 1A ,B, the protein and mRNA expression levels of RIZ1 were significantly increased in both HeLa and SiHa cells transfected with RIZ1 overexpression plasmid as compared to those transfected with the empty vector (p < 0.001 for protein level; p < 0.01 for mRNA level).
Overexpression of RIZ1 combined with radiotherapy causes a more pronounced inhibition of the growth of cervical cancer cells in vitro. After exposure to the ionizing radiation, the colony formation abilities of RIZ1-overexpressed HeLa and SiHa cells were weaker than those of the non-transfected ones (for HeLa cells at 4 Gy, p < 0.05; at 6 Gy, p < 0.05; at 8 Gy, p < 0.01; for SiHa cells at 4 Gy, p < 0.01; at 6 Gy, p < 0.01; at 8 Gy, p < 0.001) ( fig. 2A,B) . Dq and D0 values of RIZ1-overexpressed cells were lower than those of the control vector-transfected cells ( fig. 2) .
Overexpression of RIZ1 combined with radiotherapy induces more apoptosis in vitro. As compared with the vector group, RIZ1 overexpression induced significant apoptosis in HeLa and SiHa cells Fig. 2 . Effect of RIZ1 overexpression on the colony formation ability of cervical cancer cells exposed to various doses of radiation in vitro. The clonogenic cell survival curves from HeLa (A) and SiHa (B) cells after exposure to radiation were generated. According to the multi-target singlehit model, the radiobiological parameters Dq and D0 were calculated and shown. At least three independent experiments were performed to obtain the results. All data were expressed as means AE S.D. (n = 3). Unpaired Student's t-test was performed to compare differences between two groups. *p < 0.05, **p < 0.01, ***p < 0.001, versus the vector group.
(p < 0.001 for all) ( fig. 3A-C) , and more apoptosis was observed when RIZ1 overexpression was combined with radiotherapy in HeLa and SiHa cells (for HeLa cells at 2 Gy, p < 0.01; at 4 Gy, p < 0.01; at 6 Gy, p < 0.01; at 8 Gy, p < 0.01; at 10 Gy, p < 0.01; for SiHa cells at 6 Gy, p < 0.01; at 8 Gy, p < 0.05; at 10 Gy, p < 0.01). In addition, the levels of apoptosis-related proteins were assessed by Western blot. As presented in fig. 3D -G, overexpression of RIZ1 enhanced the levels of cleaved caspase-3, cleaved PARP and P53 in cervical cancer cells with or without radiation.
Overexpression of RIZ1 combined with radiotherapy intensifies DNA damage in vitro. Here, we assessed the c-H2AX foci formation by performing immunofluorescence staining. As illustrated in fig. 4A -D, the percentage of c-H2AX-positive cells increased when RIZ1 was overexpressed, which was further enhanced in the RIZ1 overexpression and radiation group (for HeLa cells at 0 Gy, p < 0.05; at 4 Gy, p < 0.05; for SiHa cells at 10 Gy, p < 0.01), indicating that the overexpression of RIZ1 combined with radiotherapy could further promote DNA damage in cervical cancer cells. Moreover, the protein level of 53BP1, a marker for DNA double-strand breaks, was investigated. As shown in fig. 4E ,F, the level of 53BP1 was up-regulated by overexpression of RIZ1, which was further intensified in cervical cancer cells exposed to radiation.
Overexpression of RIZ1 combined with radiotherapy has a more effective suppression of tumour growth in vivo. To further verify the role of RIZ1 combined with radiotherapy in tumour growth in vivo, the nude mice carrying xenograft tumours formed by RIZ1-overexpressed or empty vector-transfected cervical cancer cells were subjected to radiation. Without radiation, tumour growth was suppressed by RIZ1 overexpression (for HeLa cells: Day 27, p < 0.05; Day 30, p < 0.05; for SiHa cells: Day 21, p < 0.05; Day 24, p < 0.05; Day 27, p < 0.01; Day 30, p < 0.01) ( fig. 5A,B) . Further, after the 15 Gy radiotherapy, the volumes (for HeLa cells: Day 24, p < 0.05; Day 27, p < 0.05; Day 30, p < 0.01; for SiHa cells: Day 24, p < 0.05; Day 27, p < 0.01; Day 30, p < 0.01) and weights (p < 0.01 for all) of tumours generated by RIZ1-overexpressed cancer cells were significantly decreased as compared to those formed by the vector-transfected cells (fig. 5 ).
In addition, tumour morphological alterations were assessed by haematoxylin and eosin staining. After radiation, tumours generated by the RIZ1-overexpressed cells had distinct nuclear condensation or fragmentation and vacuolation ( fig. 6A) Discussion RIZ1, as a tumour suppressor, plays pivotal roles in arresting tumour progression. In this study, HeLa and SiHa cell lines stably transfected with RIZ1 overexpression plasmid were successfully established and subjected to ionizing radiation. This study explores a new research direction and sheds lights on the antitumour role of RIZ1 combined with radiotherapy in cervical cancer cells.
Radiotherapy is one of the primary treatments for patients suffering from cervical cancer. Its therapeutic effect, however, is not ideal due to the radioresistance of cancer cells. With the development of molecular biology, the occurrence and development of malignant tumours are being regarded as complicated processes involving several genes. Different expression profiles of genes may account for different radiosensitivities of various tumour types [23] [24] [25] . At present, the combination of radiotherapy and genetic therapy has been applied to treat cancer -called genetic radiotherapy [26] . Our study shows that RIZ1 overexpression combined with radiotherapy led to more apoptosis and DNA damage in HeLa and SiHa cells.
Apoptosis is a programmed cell death process that maintains intracellular homoeostasis under physiological or pathological conditions. Radiotherapy exerts its anticancer effect through the induction of apoptosis [27] . DNA repair processes triggered by irradiation may protect cancer cells [28] . Thus, the identification of novel molecules that participate in radiation-induced apoptosis and DNA repair of cancer cells is needed. RIZ1, as a tumour suppressor gene, has been demonstrated to induce apoptosis in various types of cancer cells [8, 29, 30] . Our present study first confirmed the apoptosis-promoting role of RIZ1 in cervical cancer cells by directly up-regulating its expression in HeLa and SiHa cells. Further, we found that the combination of RIZ1 overexpression and radiotherapy sensitized these cells to apoptosis. Apoptosis, as a programmed process, can be accurately controlled by a series of protein signalling pathways, including mitochondria-dependent pathway, death-receptor pathway and endoplasmic reticulum stress-mediated apoptosis pathway [31, 32] . The detailed mechanisms by which RIZ1 contributes to radiation-induced apoptosis of cervical cancer cells are poorly understood and require further investigation. In this study, we suggested that apoptosis was intensified via activating P53-caspase-3 pathway in cervical cancer cells treated with radiotherapy and RIZ1 overexpression.
Ionization radiation can cause DNA damage [33] . After exposure to ionization radiation, c-H2AX, an important The weight of tumours from the vector and RIZ1 overexpression group receiving 10 Gy or 15 Gy radiotherapy. At least three independent experiments were performed to obtain the results. All data were expressed as means AE S.D. (n = 4). Unpaired Student's t-test was performed to compare differences between two groups. *p < 0.05, **p < 0.01, versus the vector group. molecular marker of DNA damage, binds to DNA doublestrand break sites, recruits damage-repair proteins and forms c-H2AX foci [34] . c-H2AX is widely used to evaluate the DNA double-strand breaks within cancer cells post-ionization radiation [35, 36] . More residual c-H2AX foci suggest an enhanced radiosensitivity of cancer cells [37] . Our results revealed more c-H2AX foci within the RIZ1-overexpressed HeLa and SiHa cells, which were further enhanced by the combination of radiotherapy and RIZ1 overexpression. Moreover, 53BP1, another marker for DNA double-strand breaks [38] , was assessed to further confirm the role of RIZ1 in DNA damage. The results indicated that 53BP1 level was significantly increased in RIZ1-overexpressed cells, which was more pronounced when the RIZ1-overexpressed cells were subjected to radiotherapy. These findings suggested that combination of radiotherapy and RIZ1 overexpression exacerbated DNA damage in cervical cancer cells.
To further verify our results, the nude mice carrying xenograft tumours formed by RIZ1-overexpressed or empty vectortransfected cervical cancer cells were subjected to radiation. A better efficiency of ionizing radiation was found in mice carrying RIZ1-overexpressed xenograft tumours. PCNA is expressed in cell nuclei, and its expression is elevated in cells at S phase (the DNA synthesis phase of cell cycle) [39] . PCNA participates in the repair of DNA via resynthesis of excised damaged DNA strands [40] [41] [42] . Our data further illustrated a down-regulated expression of PCNA in RIZ1-overexpressed tumours exposed to radiation.
In the present study, the two most common cell types of cervical cancer were used, including HeLa, adenocarcinoma carcinoma cell line and SiHa, squamous cell carcinoma cell line. According to previous studies, the patients with cervical squamous cell carcinoma and adenocarcinoma carcinoma treated with definitive radiotherapy exhibited different survival outcome, sensitivity to radiation and prognosis [43, 44] . However, our results did not reveal the obvious difference in radiosensitivity between HeLa and SiHa cells, which can also be found in several similar studies [45, 46] . This discrepancy may be because the efficacy of radiotherapy on patients is affected by many factors in vivo, while fewer factors are going to affect the cells' exposed to radiation in vitro. To our knowledge, the present work was the first one to explore the role of RIZ1 in combination with radiotherapy in cancer cells.
In conclusion, this study suggests that the combination of RIZ1 overexpression and radiotherapy inhibits cervical cancer cell growth at least in part through inducing apoptosis and DNA damage.
